查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1623168

電動骨骼生長刺激植入裝置的全球市場規模:各產品，各用途，各地區，範圍及預測

Global Electrical Bone Growth Stimulators Market Size By Product (External Type, Implanted Type), By Application (Hospitals And Clinics, Home Care, Academic And Research Institutes), By Geographic Scope And Forecast
出版日期: | 出版商: Verified Market Research | 英文 202 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

電動骨骼生長刺激器的市場規模與預測

2022 年電動骨骼生長刺激器的市場規模價值為 20.4 億美元，預計到 2030 年將達到 33 億美元，2023 年至 2030 年的複合年增長率為 5.3%。人們對非侵入性和微創手術治療的偏好日益增加是推動電骨生長刺激器市場收入成長的關鍵因素，而不斷增長的目標患者群體將推動市場成長。全球電動骨骼生長刺激器市場報告對市場進行了全面的評估。它對關鍵細分市場、趨勢、市場推動因素、阻礙因素、競爭格局以及在市場中發揮關鍵作用的因素進行了全面的分析。

全球電動骨骼生長刺激器市場的定義

骨骼生長刺激器 (BGS) 是醫療產業用來輔助骨折癒合過程的設備。 BGS 透過向骨骼輸送適量的電流，刺激最新的細胞群並使骨折更快癒合，從而增強此過程。刺激器通常用於治療難以治療的骨折、不癒合以及舟骨、脛骨遠端、股骨、肱骨和第五蹠骨幹的應力性骨折。

骨骼生長刺激透過纖維軟骨的鈣化和礦化增強骨形成環境，修復骨折部位並改善血管分佈。儘管醫療保健提供者明白骨癒合可能很複雜或受損，似乎有理由使用骨骼刺激器，但現有研究尚未證明其在某些情況下的使用是有效的。

全球電動骨骼生長刺激器市場概況

肥胖率上升和骨科損傷增多是電骨骼生長刺激器市場擴張的主要驅動力。非侵入性醫療程序的興起提高了骨移植手術的成功率，且副作用風險較低，預計也將推動對 BGS 的需求。與其他侵入性治療技術相比，BGS 的併發症發生率較低。

機車使用者的快速增加也將促使脊椎損傷的道路交通事故大幅增加，最終推動電骨骼生長刺激器市場的擴張。然而，對BGS成功率的了解不足和高昂的治療費用是骨骼生長刺激器發展的主要抑制因素。此外，對安全、創新、現代和有效的治療技術的需求不斷增加，可能為電骨骼生長刺激器市場創造機會。

目錄

第1章 電動骨骼生長刺激植入裝置的全球市場簡介

  • 市場概要
  • 調查範圍
  • 前提條件

第2章 摘要整理

第3章 VERIFIED MARKET RESEARCH的調查手法

  • 資料探勘
  • 驗證
  • 第一手資料
  • 資料來源一覽

第4章 電動骨骼生長刺激植入裝置的全球市場展望

  • 概要
  • 市場動態
    • 促進因素
    • 阻礙因素
    • 機會
  • 波特的五力分析
  • 價值鏈分析

第5章 電動骨骼生長刺激植入裝置的全球市場:各產品

  • 概要
  • 外置類型
  • 嵌入式類型

第6章 電動骨骼生長刺激植入裝置的全球市場:各用途

  • 概要
  • 醫院和診療所
  • 居家醫療
  • 學術·研究機關

第7章 電動骨骼生長刺激植入裝置的全球市場，各地區

  • 概要
  • 北美
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 其他歐洲
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 其他亞太地區
  • 全球其他地區
    • 南美
    • 中東·非洲

第8章 電動骨骼生長刺激植入裝置的全球市場:競爭情形

  • 概要
  • 企業市場排行榜
  • 主要的開發策略

第9章 企業簡介

  • Stryker
  • ITO
  • Orthofix Medical
  • Zimmer Biomet

第10章 附錄

  • 相關報告
簡介目錄
Product Code: 16315

Electrical Bone Growth Stimulators Market Size And Forecast

Electrical Bone Growth Stimulators Market size was valued at USD 2.04 Billion in 2022 and is projected to reach USD 3.3 Billion by 2030 , growing at a CAGR of 5.3% from 2023 to 2030. The growing preference for non-invasive and minimally invasive surgical treatments is the crucial aspect of the rise in the market revenue of Electrical Bone Growth Stimulators, and the increasing target patient population will foster market growth. The Global Electrical Bone Growth Stimulators Market report provides a holistic evaluation of the market. The report offers a comprehensive analysis of key segments, trends, drivers, restraints, competitive landscape, and factors that are playing a substantial role in the market.

Global Electrical Bone Growth Stimulators Market Definition

Bone growth stimulator (BGS) is a device utilized in the medical industry for the healing process of a fracture. BGS enhances this process by stimulating the assembly of the latest cells by applying the right amount of electricity to the bone, allowing the fracture to heal considerably faster. Stimulators are usually employed for hard-to-treat fractures, nonunions, and inadequately healing stress fractures of the scaphoid, distal tibia, femur, humerus, and fifth metatarsal shaft.

The bone growth stimulation leads to an enhanced osteogenic environment with calcification and mineralization of the fibrocartilage repairs the fracture site and improves vascularity. Although a healthcare provider's understanding that bone healing could also be complicated or impaired would seemingly justify the utilization of a bone stimulator, the existing research has not illustrated that the utilization of a bone stimulator under certain circumstances is effective.

Global Electrical Bone Growth Stimulators Market Overview

The rise in obesity and hence the increase in the number of orthopedic injuries are the main driving factors for the expansion of the Electrical Bone Growth Stimulators Market. The rise in non-invasive medical practices to reinforce the success of bone grafting procedures and the low risk of adverse effects also are expected to accelerate the demand for BGS. The complexity rates in BGS are low as compared to other invasive medical treatment techniques.

The rapid rise in automobile users also leads to a substantial rise in road accidents resulting in spinal injuries and therefore eventually promoting the expansion of the Electrical Bone Growth Stimulators Market. However, inadequate knowledge about the success rates of BGS and therefore the higher treatment cost are the main restraints within the growth of the bone growth stimulator. Moreover, the increasing demand for safe, innovative, and modern effective treatment techniques can create a chance for the Electrical Bone Growth Stimulators Market.

Global Electrical Bone Growth Stimulators Market: Segmentation Analysis

The Global Electrical Bone Growth Stimulators Market is Segmented on the basis of Product, Application, And Geography.

Electrical Bone Growth Stimulators Market, By Product

  • External Type
  • Implanted Type

Based on Product, the market is bifurcated into External Type and Implanted Type. The external type segment is expected to account for the largest market share in the estimated period. This can primarily be attributed to the growing aging population globally, the rising preference for non-surgical treatment procedures, and therefore the growing prevalence of nonunion fractures.

Electrical Bone Growth Stimulators Market, By Application

  • Hospitals and Clinics
  • Home Care
  • Academic and Research Institutes

Based on Application, the market is bifurcated into Hospitals and Clinics, Home Care, and Academic and Research Institutes. The hospitals and clinics segment accounted for the most important of the market. The advantages of bone growth stimulation products over their counterparts are the key factor driving their adoption during this end-user segment.

Electrical Bone Growth Stimulators Market, By Geography

  • North America
  • Europe
  • Asia Pacific
  • Rest of the world
  • On the basis of Regional Analysis, The Global Electrical Bone Growth Stimulators Market is classified into North America, Europe, Asia Pacific, and Rest of the world. The U.S. drives the expansion within the North American region as it is the largest market within the region. The Asia-Pacific region offers considerable potential for market growth attributable to the rapid climb in markets such as India and China. The APAC region is projected to experience growth at the highest CAGR.

Key Players

  • The "Global Electrical Bone Growth Stimulators Market" study report will provide valuable insight with an emphasis on the global market. The major players in the market are
  • Stryker, ITO, Orthofix Medical, Zimmer Biomet.
  • The competitive landscape section also includes key development strategies, market share, and market ranking analysis of the above-mentioned players globally.

Key Developments

  • Partnerships, Collaborations and Agreements
  • In April 2021, Orthofix Medical Inc., an international medical device firm, announced that it has entered into a formal license deal to commercialize the revolutionary portfolio of IGEA S.p. A's bone and soft tissue stimulation products in the United States and Canada. With this agreement, the firm gains the authority to obtain US Food and Drug Administration clearances for IGEA's orthopedic product platform.
  • Orthofix signed an exclusive license agreement in 2021 to commercialize IGEA's revolutionary array of bone, cartilage, and soft tissue stimulation solutions in the United States and Canada.
  • DePuy Synthes renewed its cooperation with the AO Foundation in 2020 to improve patient care and outcomes through innovation and the AO Foundation's independent worldwide education initiatives.
  • Mergers and Acquisitions
  • Stryker paid USD 5.4 billion for Wright Medical in 2020. Stryker's position in the orthopedics device industry was reinforced as a result of the acquisition.
  • Medtronic plc announced in January 2020 that it had acquired Stimgenics, LLC, a privately held business that has developed a unique spinal cord stimulation (SCS) therapy. This therapy is given via the Medtronic Intellis platform and is a new and exclusive programming option for treating chronic pain patients.
  • In February 2019, Colfax Corporation paid $3.15 billion to acquire DJO Global Inc. from an investment group led by private equity funds managed by Blackstone. With this acquisition, Colfax Corporation intends to achieve significant development in the orthopedic solutions industry.
  • Product Launches and Product Expansions
  • Orthofix Medical Inc., a medical device firm, announced the FDA approval of the STIM Ontrack mobile app version to be utilized by the company's bone growth stimulators in February 2020. This technology works in conjunction with the Orthofix bone growth therapy devices to help patients adhere to their prescriptions and advance their clinical results.
  • Orthofix International N.V. releases its next-generation bone growth stimulators, Cervical-Stim and Spinal-Stim, in April 2017. These gadgets are intended to encourage and boost the body's natural healing process following a spinal fusion operation.

TABLE OF CONTENTS

1. INTRODUCTION OF GLOBAL ELECTRICAL BONE GROWTH STIMULATORS MARKET

  • 1.1 Overview of the Market
  • 1.2 Scope of Report
  • 1.3 Assumptions

2 EXECUTIVE SUMMARY

3 RESEARCH METHODOLOGY OF VERIFIED MARKET RESEARCH

  • 3.1 Data Mining
  • 3.2 Validation
  • 3.3 Primary Interviews
  • 3.4 List of Data Sources

4. GLOBAL ELECTRICAL BONE GROWTH STIMULATORS MARKET OUTLOOK

  • 4.1 Overview
  • 4.2 Market Dynamics
    • 4.2.1 Drivers
    • 4.2.2 Restraints
    • 4.2.3 Opportunities
  • 4.3 Porters Five Force Model
  • 4.4 Value Chain Analysis

5. GLOBAL ELECTRICAL BONE GROWTH STIMULATORS MARKET, BY PRODUCT

  • 5.1 Overview
  • 5.2 External Type
  • 5.3 Implanted Type

6. GLOBAL ELECTRICAL BONE GROWTH STIMULATORS MARKET, BY APPLICATION

  • 6.1 Overview
  • 6.2 Hospitals and Clinics
  • 6.3 Home Care
  • 6.4 Academic and Research Institutes

7. GLOBAL ELECTRICAL BONE GROWTH STIMULATORS MARKET, BY GEOGRAPHY

  • 7.1 Overview
  • 7.2 North America
    • 7.2.1 U.S.
    • 7.2.2 Canada
    • 7.2.3 Mexico
  • 7.3 Europe
    • 7.3.1 Germany
    • 7.3.2 U.K.
    • 7.3.3 France
    • 7.3.4 Rest of Europe
  • 7.4 Asia Pacific
    • 7.4.1 China
    • 7.4.2 Japan
    • 7.4.3 India
    • 7.4.4 Rest of Asia Pacific
  • 7.5 Rest of the World
    • 7.5.1 Latin America
    • 7.5.2 Middle East & Africa

8. GLOBAL ELECTRICAL BONE GROWTH STIMULATORS MARKET COMPETITIVE LANDSCAPE

  • 8.1 Overview
  • 8.2 Company Market Ranking
  • 8.3 Key Development Strategies

9. Company Profiles

  • 9.1 Stryker
    • 9.1.1 Overview
    • 9.1.2 Financial Performance
    • 9.1.3 Product Outlook
    • 9.1.4 Key Developments
  • 9.2 ITO
    • 9.2.1 Overview
    • 9.2.2 Financial Performance
    • 9.2.3 Product Outlook
    • 9.2.4 Key Developments
  • 9.3 Orthofix Medical
    • 9.3.1 Overview
    • 9.3.2 Financial Performance
    • 9.3.3 Product Outlook
    • 9.3.4 Key Developments
  • 9.4 Zimmer Biomet
    • 9.4.1 Overview
    • 9.4.2 Financial Performance
    • 9.4.3 Product Outlook
    • 9.4.4 Key Developments

10. Appendix

  • 10.1 Related Reports